Talphera: Funding, Investors & Team (Sep 2026)
Talphera is a pharmaceutical company that focuses on developing and selling therapies in medically supervised environments. They have a product called NanoTab, which is a tablet designed for oral transmucosal administration. Additionally, the company offers the Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system used to manage acute postoperative pain in hospitals. They also have the Sufentanil NanoTab BTP management systems, which serve as a treatment option for patients with cancer pain. Lastly, they provide the Sufentanil/Triazolam NanoTab, which offers both analgesia and sedation for minor outpatient procedures.
Talphera has raised $8.0M across 1 funding round on record, the most recent an undisclosed round of $8.0M announced in Jan 2024.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Talphera Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Talphera Funding Rounds
Talphera Founders and Leadership Team
Contact details for the Talphera team: 1 of 1 has an email address on file.
Start 14-day free trial →Talphera Funding Compared to Other Biotechnology Startups
Talphera's latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Talphera in Biotechnology and Redwood City
Companies Similar to Talphera
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Talphera Funding FAQs
What does Talphera do?
Talphera is a pharmaceutical company that focuses on developing and selling therapies in medically supervised environments. They have a product called NanoTab, which is a tablet designed for oral transmucosal administration. Additionally, the company offers the Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system used to manage acute postoperative pain in hospitals. They also have the Sufentanil NanoTab BTP management systems, which serve as a treatment option for patients with cancer pain. Lastly, they provide the Sufentanil/Triazolam NanoTab, which offers both analgesia and sedation for minor outpatient procedures.
How much funding has Talphera raised?
Talphera has raised $8.0M across 1 round on record. The most recent is an undisclosed round of $8.0M announced in Jan 2024.
When did Talphera last raise funding?
Talphera's most recent funding round on record is an undisclosed round of $8.0M, announced in Jan 2024.
Who founded Talphera?
FundedIQ lists Pamela Pierce Palmer (Founder) at Talphera.
Where is Talphera headquartered?
Talphera is based in Redwood City, California, United States.
How many employees does Talphera have?
Talphera is in the 11-50 employee band.
How does Talphera's funding compare to other Biotechnology startups?
Talphera's latest round of $8.0M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Talphera Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Talphera is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.